Journal of Clinical Case Reports and Case Studies最新文献

{"title":"Contrast-Induced Acute Pancreatitis after Cerebral Arteriography","authors":"L. Gatto, Thiago Ferreira Souza, G. Koppe, Zeferino Demartini","doi":"10.29199/2637-9309/cccs-202023","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs-202023","url":null,"abstract":"Although kidney failure due to iodinated contrast medium is relatively common, the well-established relation of these agents with pancreatitis is not yet well established. The few reports in the literature associating pancreatitis with radiographic contrasts demonstrate, in animal studies, a possible clinical worsening in an ongoing pancreatitis. Contrast-induced pancreatitis is an extremely rare adverse event, usually presenting with mild symptoms. We report two cases of patients submitted to cerebral digital subtraction angiography due to cerebrovascular diseases, both evolving with pancreatic enzyme elevation with other causes excluded by a multidisciplinary team.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121759016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cerebral Venous Thrombosis in a Pediatric Patient with Antithrombin Deficiency","authors":"A. Marco, P. Marco","doi":"10.29199/2637-9309/cccs.201020","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs.201020","url":null,"abstract":"Massive cerebral vein thrombosis in the context of antithrombin deficiency is an extremely rare but severe condition, even fatal. Here we describe an unusual case of a pediatric patient diagnosed of antithrombin deficiency that developed seizures and loss of consciousness in the context of extensive deep cerebral vein thrombosis. Anticoagulation therapy with heparin and antithrombin replacement are the first treatment options in acute phase. Endovascular thrombolysis with or without mechanical thrombectomy may be beneficial in patients with poor prognosis despite anticoagulation. Our patient is currently on long-term anticoagulation with vitamin K antagonists and remains asymp-tomatic.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131565394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Magnetic Resonance Imaging Evaluation in Ischemic Priapism Secondary to Quetiapine Prescribed for Sleep Disturbance","authors":"Chelsea A. Sparks, D. Ivancsits, R. Kedar","doi":"10.29199/2637-9309/cccs-102017","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs-102017","url":null,"abstract":"Ischemic priapism is a low-flow state of priapism, an erection lasting >4 hours, and represents the most common subtype. It is a urological emergency which should be managed urgently to avoid complications of erectile dysfunction and fibrosis. The association of antipsychotic medications, including quetiapine, with priapism is well documented. Magnetic resonance imaging (MRI) has utility in the evaluation of fibrosis and the viability of the corpora cavernosa in ischemic priapism, in cases where ultrasound findings may be difficult to interpret, and in cases of prolonged ischemic priapism. We present a case of recurrent ischemic priapism secondary to quetiapine prescribed for sleep disturbance with associated penile ultrasound and MRI findings.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126204407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Already Rare Malignant Solitary Fibrous Tumor of the Prostate With Metastasis to the Lung: A Case Report, and Review of the Literature","authors":"Ahmed M El Farrah","doi":"10.29199/2637-9309/cccs-101016","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs-101016","url":null,"abstract":"This is the 23rd ever reported SFT of the prostate, and of the 22 others, the 5th metastatic SFT reported. We report this rare case in a 72-year-old male presenting with intermittent urinary retention and constipation. Our research lead us to a unique case of an already rare SFT in the prostate, as well as remarkably 'multiple first's' that have never been considered or reported within the current literature. A Solitary fibrous tumor (SFT), also known as fibrous tumor of the pleura, is a rare mesenchymal type tumor usually originating in the pleura and rarely any soft tissue site including the seminal vesicle. About 85% of SFT's are benign (conventional) and 15% are metastatic (ma-lignant). Somatic fusions of four gene types, STAT6 located at chromosomal region 12q13, and the other three bcl-2, CD99, and CD34 (mostly conventional type) have been identified in solitary fibrous tumors. Currently, the treatment of choice for both conventional and malignant SFT's is surgical resection. radiotherapy in malignant SFT’s remain controversial.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128507584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Awareness and a Postulated Pathway for Testicular Tumors Forming in an Obese Society with Simultaneous Legalization of Cannabinoid’s. Case Report and Literature Review","authors":"Ahmed M El Farrah","doi":"10.29199/2637-9309/cccs-101014","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs-101014","url":null,"abstract":"Current physiology in the body uses endogenous cannabinoids to do specific functions. Recently there has been evidence to show that there is alteration of cannabinoid receptor sites with use of exogenous cannabinoid (marijuana) use. Exogenous cannabinoid use has been linked to some detrimental effects including depressed CNS activity, increased lipogenesis, and the formation of testicular masses with potentially fatal outcomes. This article presents a 33 y/o male who lived a sedentary life style and used cannabinoids casually and presented with a painful testicular mass. This article is the first to postulate a pathway in obese patients using exogenous cannabinoids; and its effects causing testicular masses. Also, this article hopefully brings awareness to clinicians concerning the effects of exogenous cannabinoids utilizing endogenous cannabinoid pathways and emphasizes the importance of thorough H/P’s; and social histories in a society rapidly legalizing cannabinoid use.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129117160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Unusual Case of Esophageal Rupture","authors":"N. Tejani, Sylvia Bowditch, K. Engstad, L. Ranasinghe","doi":"10.29199/2637-9309/cccs-101015","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs-101015","url":null,"abstract":"Boerhaave Syndrome is a rare entity which occurs as a result of rupture of the distal esophagus leading to a high rate of morbid-ity and mortality. It occurs most frequently in patients with bulimia or alcoholism because of the increased episodes of emesis and underlying esophageal fragility. We present a unique case of a 38-year old firefighter / paramedic with no prior risk factors for esophageal rupture who sustained this injury after three bouts of emesis. The diagnosis of Boerhaave Syndrome was initially missed by the emergency physician, who attributed the patient’s condition to nephrolithiasis. A radiologist’s attention to detail ultimately led to the correct diagnosis. Our patient underwent surgery to repair the tear and required extensive follow-up care. Pathophysiology, epidemiology, imaging, management, and complications are discussed in this case report.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116363831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Performance of iPhone Hyperemesis Gravidarum Care App","authors":"Edwin Korouri, Kimber MacGibbon, M. Chan, L. Guba, L. Cruz, William, Leung, John Wang, K. Jensen, M. Fejzo","doi":"10.29199/2637-9309/cccs.201023","DOIUrl":"https://doi.org/10.29199/2637-9309/cccs.201023","url":null,"abstract":"Introduction: Hyperemesis Gravidarum (HG), severe nausea and vomiting in pregnancy, occurs in up to 2% of pregnancies, leads to significant weight loss, prolonged malnutrition and dehydration, and is associated with both maternal and fetal morbidity. Patients with HG often need help monitoring their care due to being ill throughout pregnancy. We created a mobile application to help HG patients track their symptoms and medications with the objective of improving care and communication. Methods: The study was performed at the University of California, Los Angeles (UCLA). Patients were invited to participate in the study at their doctor visit at UCLA and/or through social media. Interested participants were asked to use an iPhone app to record symptoms, intake, and medications for 7 days prior to their next prenatal appointment. Copies of data were given to their provider, and both the patient and provider completed an app success survey at the appointment. Feedback was requested from both the patient and provider on the App’s effectiveness for defining symptom level, improving communication, and improving treatment of HG, as well as any suggestions for improvements for the HG Care App. Results: Thirty-six patients participated in symptom tracking and provided feedback, and 6 providers gave feedback on the App. Data analysis showed that patients felt positive about the App’s ability to accurately define symptom levels (92%), improve communication (66%), and improve care (61%). Providers unanimously thought the HG Care App was accurate in defining symptom levels and was useful in improving communication, and most (67%) found it useful in improving care. Common feedback regarding the App included: being tedious to fill out (22%), being able to more easily explain symptoms to one’s provider (14%), and adding a daily reminder to input symptoms in future versions (11%). Discussion: A majority of both patients and providers are proponents of using the HG mobile application for accurately defining symptom levels and improving quality of care and communication. Users requested improvements to App UI, and additional features be included in future versions. Results indicate that mobile apps have potential to be effective tools towards treating HG and severe NVP.","PeriodicalId":280134,"journal":{"name":"Journal of Clinical Case Reports and Case Studies","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122374077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}